L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor
Authors:
- Philip E.J. SandersonPSPhilip E.J. Sanderson
- Kellie J. CutronaKCKellie J. Cutrona
- Bruce D. DorseyBDBruce D. Dorsey
- Dona L. DyerDDDona L. Dyer
- Colleen M. McDonoughCMColleen M. McDonough
- Adel M. Naylor-OlsenANAdel M. Naylor-Olsen
- I-Wu ChenICI-Wu Chen
- Zhongguo ChenZCZhongguo Chen
- Jacquelynn J. CookJCJacquelynn J. Cook
- Stephen J. GardellSGStephen J. Gardell
- Julie A. KruegerJKJulie A. Krueger
- S.Dale LewisSLS.Dale Lewis
- 1 April 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (7) , 817-822
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Discovery and Development of the Novel Potent Orally Active Thrombin Inhibitor N-(9-Hydroxy-9-fluorenecarboxy)prolyl trans-4-Aminocyclohexylmethyl Amide (L-372,460): Coapplication of Structure-Based Design and Rapid Multiple Analogue Synthesis on Solid SupportJournal of Medicinal Chemistry, 1998
- Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 PositionJournal of Medicinal Chemistry, 1997
- Design and synthesis of a novel class of thrombin inhibitors incorporating heterocyclic dipeptide surrogatesBioorganic & Medicinal Chemistry Letters, 1997
- L-373,890, An achiral, noncovalent, subnanomolar thrombin inhibitorBioorganic & Medicinal Chemistry Letters, 1997
- Potent Noncovalent Thrombin Inhibitors That Utilize the Unique Amino Acid d-Dicyclohexylalanine in the P3 Position. Implications on Oral Bioavailability and Antithrombotic EfficacyJournal of Medicinal Chemistry, 1997
- Design of Highly Potent Noncovalent Thrombin Inhibitors That Utilize a Novel Lipophilic Binding Pocket in the Thrombin Active SiteJournal of Medicinal Chemistry, 1997
- CVS-1123, A Direct Thrombin Inhibitor, Prevents Occlusive Arterial and Venous Thrombosis in a Canine Model of Vascular InjuryJournal of Cardiovascular Pharmacology, 1997
- Orally Effective CVS-1123 Prevents Coronary Artery Thrombosis in the Conscious DogCirculation, 1996
- Challenges in the development of orally bioavailable thrombin active site inhibitorsBlood Coagulation & Fibrinolysis, 1995
- Synthetic Low-Molecular Weight Thrombin Inhibitors: The Ideal Antithrombotic Drug? an IntroductionJournal of Enzyme Inhibition, 1995